Monoklonal gammopati med ubestemt signifikans

Niels Emil Ulrich Hermansen, Trine Silkjaer, Charlotte Toftmann Hansen, Thomas Granum Aagaard, Henrik Gregersen

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review


This review summarises the work-up of patients with monoclonal gammopathy of undetermined significance (MGUS). In persons above 70 years of age, around 5% have MGUS, a premalignant state with a monoclonal plasma immunoglobulin or light chain (M protein) in blood and/or urine. Continuous follow-up is recommended due to a risk of malignant progression of around 1% per year. Immunoglobulin M MGUS primarily progresses to Waldenström’s macroglobulinaemia, whereas non-immunoglobulin M MGUS typically progresses to multiple myeloma or amyloid light-chain amyloidosis. Treatment is unnecessary unless in rare cases of severe non-malignant complications. Screening is not advised.
Bidragets oversatte titelMonoclonal gammopathy of undetermined significance
TidsskriftUgeskrift for Laeger
Udgave nummer20
StatusUdgivet - 2. mar. 2020


Dyk ned i forskningsemnerne om 'Monoklonal gammopati med ubestemt signifikans'. Sammen danner de et unikt fingeraftryk.